FDA Drug Application (018163) for RESTORIL by MALLINCKRODT INC

Back to FDA Applications sponsored by MALLINCKRODT INC

Application Number018163
Product Number001
FormCAPSULE;ORAL
Dosage15MG
Product Market Status Prescription
Therapeutic Equivalence Evaluation Code AB Products meeting necessary bioequivalence requirements
Reference Drug
Drug NameRESTORIL
Active IngredientTEMAZEPAM



Back to FDA Applications sponsored by MALLINCKRODT INC

Problems, Comments, Suggestions? Click here to contact Greg Thatcher

Please read my Disclaimer





Copyright (c) 2013 Thatcher Development Software, LLC. All rights reserved. No claim to original U.S. Gov't works.